AbbVie
ABBV
ABBV
3,351 hedge funds and large institutions have $228B invested in AbbVie in 2024 Q1 according to their latest regulatory filings, with 216 funds opening new positions, 1,323 increasing their positions, 1,480 reducing their positions, and 115 closing their positions.
New
Increased
Maintained
Reduced
Closed
Holders
3,351
Holders Change
+54
Holders Change %
+1.64%
% of All Funds
48.58%
Holding in Top 10
222
Holding in Top 10 Change
+22
Holding in Top 10 Change %
+11%
% of All Funds
3.22%
New
216
Increased
1,323
Reduced
1,480
Closed
115
Calls
$3.29B
Puts
$2.55B
Net Calls
+$735M
Net Calls Change
-$1.34B
Top Buyers
Top Sellers
| 1 |
Morgan Stanley
New York
|
$6.4B |
| 2 |
Pacer Advisors
Malvern,
Pennsylvania
|
$72.2M |
| 3 |
Bank of New York Mellon
New York
|
$3.61B |
| 4 |
Assenagon Asset Management
Senningerberg,
Luxembourg
|
$57.8M |
| 5 |
Goldman Sachs
New York
|
$1.62B |
